pre-seed
Stage
2020
Founded
1
Investors
About
Anacalypsis Therapeutics is a biotech startup focused on the discovery and development of precision gene- and pathway-based disease-modifying therapeutic strategies to treat neurodegenerative diseases such as Parkinson’s Disease. They develop biomarkers for early detection and innovative treatments aimed at modifying disease progression.
Explore Anacalypsis Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.